Great Point Partners’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-200,000
Closed -$3.22M 30
2024
Q3
$3.22M Buy
+200,000
New +$3.22M 0.95% 27
2018
Q1
Sell
-5,930
Closed -$1.75M 36
2017
Q4
$1.75M Sell
5,930
-24,132
-80% -$7.1M 0.3% 34
2017
Q3
$16.5M Sell
30,062
-1,188
-4% -$650K 3.2% 11
2017
Q2
$18.6M Buy
+31,250
New +$18.6M 3.34% 13